Rhodiola In the Future
One can probably muster some cynicism when it comes to wondering why safe, natural treatments like Rhodiola Rosea are passed over for more profitable developments by pharmaceutical companies. But when you look at the foundation of evidence and promise available for Rhodiola Rosea, you still muster hope as well. Hope that someone will appreciate how and why it deserves some controlled clinical trials in the United States. Hope that a safe, inexpensive herbal remedy might elicit the curiosity of a few good researchers.
With so many promising benefits and so few side effects, I expect this change any day. But in this section of Rhodiola Rosea Phytomedicinal Overview, Dr. Patricia Gerbarg, Dr. Richard Brown, and Dr. Zakir Ramazanov implored the science community to explore the possibility of rhodiola research a full ten years ago. I still hold to the promise that the science community will want to see what can be done with the promising properties of this natural herbal remedies. The default skepticism for anything considered natural or herbal should be replaced with the curiosity and creativity for how to isolate and amplify the beneficial properties of something like R. rosea or its rosavins.
Read on to learn why Dr. Patricia Gerbarg, Dr. Richard Brown, and Dr. Zakir Ramazanov felt hope and urgency for additional research.